Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases
Cells · 09.05.2024 · 13 (10) · 805
DOI: 10.3390/cells13100805 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 09.05.2024. Verfasst von Zun Mao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China. Hauptthemen laut MEDLINE: Liver Diseases, N-Acetylglucosaminyltransferases, Acetylglucosamine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions of China, Postgraduate Research & Practice Innovation Program of Jiangsu Province, Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (Originalsprache)
O-linked-β-D-N-acetylglucosamine (O-GlcNAc) glycosylation (O-GlcNAcylation), which is dynamically regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), is a post-translational modification involved in multiple cellular processes. O-GlcNAcylation of proteins can regulate their biological functions via crosstalk with other post-translational modifications, such as phosphorylation, ubiquitination, acetylation, and methylation. Liver diseases are a major cause of death worldwide; yet, key pathological features of the disease, such as inflammation, fibrosis, steatosis, and tumorigenesis, are not fully understood. The dysregulation of O-GlcNAcylation has been shown to be involved in some severe hepatic cellular stress, viral hepatitis, liver fibrosis, nonalcoholic fatty acid liver disease (NAFLD), malignant progression, and drug resistance of hepatocellular carcinoma (HCC) through multiple molecular signaling pathways. Here, we summarize the emerging link between O-GlcNAcylation and hepatic pathological processes and provide information about the development of therapeutic strategies for liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.
- Department of Clinical Medicine, Xuzhou Medical University, Xuzhou 221004, China.
- Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA.
- Department of Hematology and Oncology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA.
- Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.
ORCID-Profile: Shile Huang, Long Chen
Förderung
- Priority Academic Program Development of Jiangsu Higher Education Institutions of China
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- LSU Collaborative Cancer Research Initiative Award
Zitieren
APA
Mao, Z., Mu, J., Gao, Z., Huang, S., & Chen, L. (2024). Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases. Cells, 13(10), 805. https://doi.org/10.3390/cells13100805
Vancouver
Mao Z, Mu J, Gao Z, Huang S, Chen L. Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases. Cells. 2024;13(10):805. doi:10.3390/cells13100805
BibTeX
@article{Mao2024,
author = {Mao, Zun and Mu, Junpeng and Gao, Zhixiang and Huang, Shile and Chen, Long},
title = {Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases},
journal = {Cells},
year = {2024},
volume = {13},
number = {10},
pages = {805},
doi = {10.3390/cells13100805}
}
EUVIMED